K
Knight Therapeutics Inc
OTC:KHTRF
Knight Therapeutics Inc
OTC:KHTRF
Price:
4.33
USD
Market Closed
Market Cap:
$439m
Balance Sheet
Balance Sheet Decomposition
Knight Therapeutics Inc
Knight Therapeutics Inc
Balance Sheet Decomposition is not available for
Knight Therapeutics Inc
Knight Therapeutics Inc
Balance Sheet
Knight Therapeutics Inc
Knight Therapeutics Inc
Currency: CAD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
283
|
238
|
515
|
497
|
245
|
169
|
230
|
86
|
72
|
59
|
80
|
|
| Cash |
0
|
0
|
0
|
491
|
245
|
164
|
227
|
77
|
71
|
58
|
75
|
|
| Cash Equivalents |
283
|
238
|
515
|
6
|
0
|
5
|
3
|
9
|
0
|
0
|
5
|
|
| Short-Term Investments |
144
|
257
|
273
|
291
|
459
|
259
|
182
|
77
|
119
|
99
|
83
|
|
| Total Receivables |
1
|
3
|
11
|
9
|
12
|
112
|
82
|
67
|
110
|
110
|
123
|
|
| Accounts Receivables |
0
|
0
|
3
|
2
|
3
|
104
|
63
|
55
|
95
|
89
|
105
|
|
| Other Receivables |
1
|
2
|
8
|
7
|
9
|
8
|
20
|
12
|
15
|
22
|
18
|
|
| Inventory |
1
|
2
|
1
|
1
|
1
|
71
|
57
|
72
|
92
|
92
|
103
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
11
|
2
|
2
|
2
|
5
|
8
|
|
| Total Current Assets |
429
|
500
|
800
|
799
|
718
|
622
|
552
|
305
|
396
|
365
|
397
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
29
|
26
|
30
|
23
|
18
|
20
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
29
|
26
|
30
|
23
|
18
|
20
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
5
|
11
|
33
|
22
|
48
|
|
| Intangible Assets |
1
|
3
|
14
|
13
|
18
|
173
|
157
|
350
|
339
|
290
|
284
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
88
|
78
|
75
|
82
|
80
|
86
|
|
| Note Receivable |
36
|
32
|
0
|
0
|
23
|
46
|
42
|
43
|
44
|
49
|
56
|
|
| Long-Term Investments |
20
|
107
|
171
|
189
|
290
|
260
|
175
|
179
|
156
|
116
|
92
|
|
| Other Long-Term Assets |
2
|
7
|
6
|
5
|
3
|
87
|
10
|
8
|
16
|
27
|
28
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
88
|
78
|
75
|
82
|
80
|
86
|
|
| Total Assets |
487
N/A
|
649
+33%
|
991
+53%
|
1 006
+2%
|
1 052
+5%
|
1 305
+24%
|
1 040
-20%
|
992
-5%
|
1 055
+6%
|
945
-10%
|
964
+2%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
73
|
45
|
65
|
106
|
85
|
78
|
|
| Accrued Liabilities |
2
|
2
|
3
|
5
|
5
|
22
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
52
|
54
|
28
|
20
|
20
|
20
|
|
| Other Current Liabilities |
6
|
4
|
7
|
9
|
11
|
204
|
16
|
12
|
15
|
9
|
13
|
|
| Total Current Liabilities |
8
|
7
|
10
|
14
|
17
|
351
|
114
|
105
|
141
|
114
|
111
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
10
|
3
|
13
|
57
|
50
|
29
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
28
|
22
|
12
|
4
|
3
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
104
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
5
|
2
|
15
|
20
|
26
|
32
|
24
|
|
| Total Liabilities |
8
N/A
|
7
-9%
|
11
+61%
|
15
+33%
|
22
+47%
|
495
+2 169%
|
153
-69%
|
150
-2%
|
229
+53%
|
199
-13%
|
169
-15%
|
|
| Equity | ||||||||||||
| Common Stock |
341
|
439
|
760
|
762
|
762
|
724
|
694
|
629
|
599
|
540
|
534
|
|
| Retained Earnings |
126
|
160
|
179
|
197
|
233
|
53
|
175
|
192
|
162
|
151
|
155
|
|
| Additional Paid In Capital |
2
|
7
|
10
|
12
|
14
|
17
|
19
|
22
|
24
|
26
|
26
|
|
| Unrealized Security Profit/Loss |
7
|
14
|
15
|
20
|
12
|
8
|
9
|
8
|
8
|
8
|
0
|
|
| Other Equity |
3
|
22
|
15
|
1
|
33
|
26
|
7
|
8
|
49
|
38
|
80
|
|
| Total Equity |
479
N/A
|
642
+34%
|
980
+53%
|
991
+1%
|
1 030
+4%
|
811
-21%
|
886
+9%
|
842
-5%
|
826
-2%
|
747
-10%
|
795
+6%
|
|
| Total Liabilities & Equity |
487
N/A
|
649
+33%
|
991
+53%
|
1 006
+2%
|
1 052
+5%
|
1 305
+24%
|
1 040
-20%
|
992
-5%
|
1 055
+6%
|
945
-10%
|
964
+2%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
91
|
104
|
133
|
143
|
143
|
136
|
130
|
118
|
112
|
101
|
100
|
|
Switch to:
Switch to:
See Also
Discover More
